Literature DB >> 33012205

Impaired Hedgehog-Gli1 Pathway Activity Underlies the Vascular Phenotype of Polycystic Kidney Disease.

Federico Franchi1, Karen M Peterson1, Katherine Quandt1, David Domnick1, Timothy L Kline2, Michaela Olthoff1, Mojtaba Parvizi1, Ezequiel J Tolosa3, Vicente E Torres4, Peter C Harris4, Martin E Fernandez-Zapico3, Martin G Rodriguez-Porcel1.   

Abstract

Polycystic kidney disease (PKD) has been linked to abnormal structure/function of ciliary proteins, leading to renal dysfunction. Recently, attention has been focused in the significant vascular abnormalities associated with PKD, but the mechanisms underlying this phenomenon remain elusive. Here, we seek to define the molecular events regulating the angiogenic imbalance observed in PKD. Using micro computed tomography (n=7) and protein expression analysis (n=5), we assessed the vascular density and the angiogenic profile of noncystic organs in a well-established PKD rat model (Polycystic Kidney-PCK rat). Heart and lungs of PCK rats have reduced vascular density and decreased expression of angiogenic factors compared with wild type. Similarly, PCK-vascular smooth muscle cells (VSMCs; n=4) exhibited lower levels of vascular markers. Then, using small interfering RNA (n=4), we determined the role of the ciliary protein fibrocystin in wild type-VSMCs, a critical component/regulator of vascular structure and function. Reduction of fibrocystin in wild type-VSMCs (n=4) led to an abnormal angiogenic potential similar to that observed in PCK-VSMCs. Furthermore, we investigated the involvement of the hedgehog signaling, a pathway closely linked to the primary cilium and associated with vascular development, in PKD. Mechanistically, we demonstrated that impairment of the hedgehog signaling mediates, in part, this abnormal angiogenic phenotype. Lastly, overexpression of Gli1 in PCK-VSMCs (n=4) restored the expression levels of proangiogenic molecules. Our data support a critical role of fibrocystin in the abnormal vascular phenotype of PKD and indicate that a dysregulation of hedgehog may be responsible, at least in part, for these vascular deficiencies.

Entities:  

Keywords:  cell signaling; cilia; hedgehog pathway; kidney; vascular smooth muscle

Year:  2020        PMID: 33012205      PMCID: PMC7666088          DOI: 10.1161/HYPERTENSIONAHA.120.15483

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  42 in total

1.  Protein kinase A acts at the basal body of the primary cilium to prevent Gli2 activation and ventralization of the mouse neural tube.

Authors:  Miquel Tuson; Mu He; Kathryn V Anderson
Journal:  Development       Date:  2011-10-17       Impact factor: 6.868

Review 2.  Autosomal dominant polycystic kidney disease: the last 3 years.

Authors:  Vicente E Torres; Peter C Harris
Journal:  Kidney Int       Date:  2009-05-20       Impact factor: 10.612

Review 3.  Angiogenesis.

Authors:  Donald R Senger; George E Davis
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-08-01       Impact factor: 10.005

Review 4.  Clinical manifestations of autosomal recessive polycystic kidney disease (ARPKD): kidney-related and non-kidney-related phenotypes.

Authors:  Rainer Büscher; Anja K Büscher; Stefanie Weber; Julia Mohr; Bianca Hegen; Udo Vester; Peter F Hoyer
Journal:  Pediatr Nephrol       Date:  2013-10-10       Impact factor: 3.714

5.  Polycystic kidneys have decreased vascular density: a micro-CT study.

Authors:  Rende Xu; Federico Franchi; Brent Miller; John A Crane; Karen M Peterson; Peter J Psaltis; Peter C Harris; Lilach O Lerman; Martin Rodriguez-Porcel
Journal:  Microcirculation       Date:  2013-02       Impact factor: 2.628

6.  The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.

Authors:  D J Lager; Q Qian; R J Bengal; M Ishibashi; V E Torres
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

7.  Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.

Authors:  Salim S Virani; Alvaro Alonso; Emelia J Benjamin; Marcio S Bittencourt; Clifton W Callaway; April P Carson; Alanna M Chamberlain; Alexander R Chang; Susan Cheng; Francesca N Delling; Luc Djousse; Mitchell S V Elkind; Jane F Ferguson; Myriam Fornage; Sadiya S Khan; Brett M Kissela; Kristen L Knutson; Tak W Kwan; Daniel T Lackland; Tené T Lewis; Judith H Lichtman; Chris T Longenecker; Matthew Shane Loop; Pamela L Lutsey; Seth S Martin; Kunihiro Matsushita; Andrew E Moran; Michael E Mussolino; Amanda Marma Perak; Wayne D Rosamond; Gregory A Roth; Uchechukwu K A Sampson; Gary M Satou; Emily B Schroeder; Svati H Shah; Christina M Shay; Nicole L Spartano; Andrew Stokes; David L Tirschwell; Lisa B VanWagner; Connie W Tsao
Journal:  Circulation       Date:  2020-01-29       Impact factor: 29.690

8.  Mesenchymal Stromal Cells Improve Renovascular Function in Polycystic Kidney Disease.

Authors:  Federico Franchi; Karen M Peterson; Rende Xu; Brent Miller; Peter J Psaltis; Peter C Harris; Lilach O Lerman; Martin Rodriguez-Porcel
Journal:  Cell Transplant       Date:  2014-10-06       Impact factor: 4.064

Review 9.  New insights into polycystic kidney disease and its treatment.

Authors:  V E Torres
Journal:  Curr Opin Nephrol Hypertens       Date:  1998-03       Impact factor: 2.894

10.  Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease.

Authors:  T Ring; D Spiegelhalter
Journal:  Kidney Int       Date:  2007-09-19       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.